Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Cancer Cell
; 41(1): 210-225.e5, 2023 01 09.
Article
in En
| MEDLINE
| ID: mdl-36584673
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, Large B-Cell, Diffuse
/
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article